Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Latest filing published 17 Mar 2026 for Stoke Therapeutics, Inc., €19k. Read the official filing
Filing timeline
BuySaleArthur A. Levin
Insider track record
Disclosed buys
0
Disclosed sells
10
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Arthur A. Levin: trading record in brief
Arthur A. Levin (senior executive) discloses dealings in 2 companies, chiefly Avidity Biosciences, Inc. and Stoke Therapeutics, Inc. The record holds 39 filings, for trades running from 14 June 2021 to 13 March 2026.
No open-market purchase appears, only 10 sales worth €2.8M. The rest of the record consists of 2 share grants and 23 option exercises. So far in 2026, the count stands at no purchases and 2 sales.
The record was last updated on 17 March 2026 with an open-market sale (€19k) in Stoke Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Arthur A. Levin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations39 total
605 shares@ US$36.80100.0% of flowCommon StockSEC:0001181556-26-000005:0
16,562 sharesCommon StockSEC:0001193125-26-082154:0
1,758 shares@ US$72.452.1% of flowCommon StockSEC:0001599901-26-000022:0
1,211 shares0Common StockSEC:0001181556-26-000003:0
1,330 shares0Common StockSEC:0001599901-25-000228:0
1,211 shares0Common StockSEC:0001181556-25-000006:0
107,500 shares@ US$22.3441.6% of flowCommon StockSEC:0001599901-25-000152:0
1,210 shares0Common StockSEC:0001415889-25-019002:0
6,692 shares0Common StockSEC:0001599901-25-000123:0
1,210 shares0Common StockSEC:0001415889-25-009616:0
1,872 shares@ US$28.59871.6% of flowCommon StockSEC:0001599901-25-000043:0
3,323 shares@ US$1.240.1% of flowCommon StockSEC:0001599901-24-000193:0
5,000 shares@ US$1.240.2% of flowCommon StockSEC:0001599901-24-000172:0
5,000 shares@ US$1.240.2% of flowCommon StockSEC:0001599901-24-000154:0
22,500 shares0Common StockSEC:0001599901-24-000148:0
22,500 shares0Common StockSEC:0001599901-24-000148:1
5,000 shares@ US$1.240.2% of flowCommon StockSEC:0001599901-24-000146:0
5,000 shares@ US$1.240.2% of flowCommon StockSEC:0001599901-24-000117:0
5,000 shares@ US$45.01386.4% of flowCommon StockSEC:0001599901-24-000117:1
5,000 shares@ US$1.240.2% of flowCommon StockSEC:0001599901-24-000113:0
40,000 shares@ US$35.065740.3% of flowCommon StockSEC:0001599901-24-000097:0
5,000 shares@ US$1.240.2% of flowCommon StockSEC:0001599901-24-000075:0
5,000 shares@ US$29.89624.3% of flowCommon StockSEC:0001599901-24-000075:1
5,000 shares@ US$1.240.2% of flowCommon StockSEC:0001599901-24-000053:0
20,000 shares@ US$27.110715.5% of flowCommon StockSEC:0001599901-24-000051:0
25 of 39 declarations
